Thursday, July 29, 2010
"Concise industry news from the US pharmaceutical industry..."
Sponsors
Platinum Sponsors
Nanopoint, Inc.
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
Gold Sponsors
Waters Corp.
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Silver Sponsors
Platinum Sponsors
Nanopoint, Inc.
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
Gold Sponsors
Waters Corp.
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Silver Sponsors
Blog
Where our team of guest writers discuss what they think about the current NGP US Issues.
Peter Duncan
Director of Business Development
Director of Business Development
Can digital pathology save drug development?
Peter Duncan of Definiens discusses the potential of digital pathology.07 Jul 2010
Focus Area: Manufacturing
1 of 3
Previous |
Next
Manufacturing
Let?s store science and let?s move science
Cryo Store BV is a Dutch logistics company with more than 10 years? experience in biotech distributing and the handling of temperature-controlled goods.
No Comments
What?s the difference between a brand name drug and a generic drug? Very little
By Neil Davey (NGP)
The generic pharmaceutical sector has seen a surge in growth as the government has eased the regulatory environment to control America?s healthcare costs.
No Comments
Healing pharma?s image
By Neil Davey
The US pharmaceutical industry is attracting unprecedented flack at present and the public?s trust has been damaged. The sector must now work to repair its reputation.
No Comments
Life sciences in the fast lane
By John D Rhodes, US & Global Managing Partner, Life Sciences, Deloitte
No Comments
1 of 3
Previous |
Next
Source: www.ngpharma.com© 2010 GDS Publishing Ltd. All rights reserved.